| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |